#USA #Boston #Operations #Perceptive Discovery #Benjamin Bronfin

Perceptive Discovery Welcomes Dr. Benjamin Bronfin

In a strategic move to enhance its operational capabilities, Perceptive Discovery has appointed Dr. Benjamin Bronfin as its new Vice President of Operations. This announcement, made on November 10, 2026, showcases the company's commitment to scaling its preclinical and translational research services, particularly in oncology and radioligand therapy.

Dr. Bronfin comes to Perceptive Discovery with an impressive portfolio of over 25 years in contract research organizations (CROs), biotechnology, and pharmaceutical development. His background places him in an ideal position to lead the organization towards its ambitious goals, focusing on both operational efficiency and improved service delivery.

Driving Operational Excellence

As Vice President, Dr. Bronfin will spearhead efforts aimed at optimizing processes and building a robust operational infrastructure that supports the growing demands for drug development. He expresses enthusiasm about joining a team rich in scientific expertise and looks forward to fostering an environment conducive to exceptional research outcomes.

Benjamin Murphy, the CEO of Perceptive Discovery, commended Dr. Bronfin's unique blend of scientific and operational skills, highlighting how his leadership is crucial in aligning the company’s operational framework with its strategic goals. “We are focused on building a delivery organization that allows our scientists to excel at their work,” he stated, indicating the high expectations set for Dr. Bronfin’s role.

Previous Experience and Proven Leadership

Before joining Perceptive Discovery, Dr. Bronfin held significant positions at Pharmaron Laboratory Services and Cambridge Biomedical. His work included enhancing service capabilities, improving operational performance, and managing intricate research programs that bridge both preclinical and clinical stages. His extensive experience overseeing multidisciplinary teams is expected to play a vital role in Perceptive’s continuous growth trajectory.

He holds a Doctor of Medicine degree from Omsk State Medical Academy, a testament to his commitment to the scientific field.

Future Outlook and Goals

In his new role, Dr. Bronfin plans to implement stronger operational processes while enhancing cross-departmental collaboration to drive key initiatives that support Perceptive Discovery's research endeavors. His vision aligns with the company’s aim to provide high-quality, reliable research services vital for sponsors making significant drug development decisions.

“This organization is on the cusp of remarkable growth,” Dr. Bronfin mentioned. “I am eager to collaborate with our talented team to streamline our operational capabilities, which will ultimately lead to better execution and high-quality research initiatives.”

Perceptive Discovery's investment in human capital underscores its resolve to handle increasingly intricate drug development tasks, integrating radiochemistry with in vitro and in vivo studies. The diverse expertise offered by the organization positions it uniquely in the market, offering sponsors necessary scientific evidence for informed decision-making in therapeutic advancements.

Conclusion

The appointment of Dr. Bronfin reflects Perceptive Discovery's dedication to enriching its operational foundation for seamless scalability, ensuring the delivery of top-tier research amidst the evolving landscape of drug development. As the company continues its mission, Dr. Bronfin's vision and expertise will undoubtedly be instrumental in shaping its future successes.